Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
09.01.2024 09:01AM
Study issued by NuWays AG
Rubean AG (von NuWays AG): BUY
BUY
FY23 sales in line with estimates // POS rollout has started; chg
Topic: Yesterday, Rubean announced to have reached more than € 1.0m in
sales (prelims) and quadrupled number of app users to c. 25k vs 6k at the
end of 2022 (eNuW).
With > € 1.0m, Rubean increased sales by >20% yoy, which is slightly better
than expected (eNuW o [ … ]
05.01.2024 09:01AM
Study issued by NuWays AG
ZEAL Network SE (von NuWays AG): BUY
BUY
Online transformation with ongoing momentum
Topic: Yesterday, the state lottery operator DLTB released its 2023 lottery
data, revealing a continuous and strong outperformance of the online
distribution channel.
Online transformation in full swing: In total, lottery players played for
c. € 2bn via online channels, marking a solid 10.4% grow [ … ]
20.12.2023 12:07PM
Study issued by First Berlin Equity Research GmbH
M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu M1 Kliniken AG
(ISIN: DE000A0STSQ8) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 11,90 auf EUR 13,20.
Zusammenfassung:
Im November stärkte M1 seine Botox-Lieferkette durch den Erwerb der Nutri
Care GmbH und ihrer hu [ … ]
18.12.2023 09:02AM
Study issued by NuWays AG
Rubean AG (von NuWays AG): BUY
BUY
PhonePOS rollout is starting right now; chg
Topic: After Rubean 1) solved its liquidity issues, 2) finally published
its FY22 figures that were in line with expectations and 3) announced
several promising partnerships, we are more optimistic that the rollout of
POS is starting right now and should have the potential to ramp-up sales.
Liquidit [ … ]
15.12.2023 09:31AM
Study issued by GBC AG
HAEMATO AG (von GBC AG): suspended
suspended
Delisting of the HAEMATO share to take place from February 2023; price
potential not yet exhausted; GBC-rating and GBC-price target suspended
HAEMATO has announced the termination of the inclusion of the shares in the
open market of 30 November 2023. The shares are to be delisted after expiry
of the notice period, at the latest by the end [ … ]
13.12.2023 10:01AM
Study issued by First Berlin Equity Research GmbH
Haemato AG (von First Berlin Equity Research GmbH): Not Rated
Not Rated
First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN:
DE000A289VV1) veröffentlicht. Analyst Ellis Acklin hat seine bisherige
Buy-Empfehlung und sein bisheriges Kursziel von EUR 34,00 wegen des
bevorstehenden Delistings zurückgenommen.
Zusammenfassung:
Haemato wird die Notierung ihrer Aktien im Open Market der Frank [ … ]
13.12.2023 09:41AM
Study issued by First Berlin Equity Research GmbH
MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG
(ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und bestätigt sein Kursziel von EUR 62,00.
Zusammenfassung:
Der NAVPS lag zum Neunmonatszeitpunkt bei €50,40 gegenüber €31,90 in 9M/22
(+58%) Die schlep [ … ]
05.12.2023 09:01AM
Study issued by NuWays AG
MAX Automation SE (von NuWays AG): BUY
BUY
Strong growth opportunities carried by structural trends; PT up
Despite a strong competitive quality and structural growth drivers, MAX
Automation had difficulties translating it into operating performance
between 2016 and 2020. Thanks to MAX having done its homework by adjusting
its portfolio and structural trends kicking in, shares look poise [ … ]
04.12.2023 09:01AM
Study issued by NuWays AG
Netfonds AG (von NuWays AG): BUY
BUY
FY23 guidance in reach after solid Q3 figures; chg
Netfonds published solid Q3 figures with further sequential top and bottom
line growth and confirmed its FY23 guidance. In detail:
Gross sales came in at € 48.4m (21% yoy, 4% qoq), broadly in line with our
estimate of € 49.0m. The sequential improvement is mainly driven by the
stron [ … ]
24.11.2023 09:27AM
Study issued by NuWays AG
NFON AG (von NuWays AG): BUY
BUY
Strong Q3 bottom-line leads to another upgrade; chg.
Yesterday, NFON released a strong set of Q3 results. While recurring
revenues were in line with our estimates, the company provided a
significant beat on the bottom line.
Q3 recurring revenues came in at € 19.4m, up 5.3% yoy (eNuW: € 19.4m) based
on a slightly increased seat base [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2025
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2025
by Gereon Kruse
#BGFL